ArticleDiagnostics (Basel, Switzerland)2021

Efficacy and Haematologic Toxicity of Palliative Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with Lutetium-177-Labeled Prostate-Specific Membrane Antigen in Heavily Pre-Treated Patients.

Murali Kesavan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.